Paras Hospitals in Northern India plans to roll out a chain of specialist outpatient maternity centres. It is one of several hospital chains which are rapidly deploying specialist outpatient chains in a race to quickly reach new consumers.
We are hearing grunts of disillusionment with the Chinese elderly care market from European operators who have examined it seriously. They say there is no goldrush.
Big for-profit healthcare operators expect to grow sales at over 10% annually for the next five years in Developed and Emerging Markets, but what do they see as their main challenges? A fascinating picture is revealed in a new survey of 81 mainly CEOs and CXOs in 37 countries of predominately large hospital chains, diagnostic lab and imaging players, commissioned by Siemens Healthineers (the new name for Siemens Healthcare) from Healthcare Business International. The quantitive survey was followed up with depth interviews with a dozen respondents.
It is confirmed: Babylon, a healthcare app allowing patients to consult a doctor on their phones, is launching in Rwanda in June. Prem Sharma, head of product, also introduced a new service that will offer a complete virtual GP experience thanks to an Artificial Intelligence (AI) triage system, at the Healthcare Business International 2016 conference's most popular session.
Plans to implement mandatory health insurance and expand capacity with new PPP contracts were laid out by Dr. Ibrahim Al-Omar, former Deputy Minister at the Saudi Ministry of Health, at our 2016 Breaking Barriers conference.
Cultural issues are at the forefront of the difficulties in running and investing into long-term care in emerging markets. At the Healthcare Business International 2016 conference, the CEOs of Senior Assist, Belgium’s third largest care home operator and a player in Latin America and Turkey, and TVM Capital, a private equity firm investing in rehabilitation in the Middle East, shared their views on the sector.
India’s fourth largest lab group, Thyrocare, will list in Mumbai on April 27. It hopes to raise INR 480 crore (US$ 72.2m) with shares priced at 420-446 rupees. Mauritian private equity group CX Partners will sell 90% of its holding and the rest is from the firm’s promoters.
As Luye Medical Group, part of the $2.5bn Hong Kong-listed pharma giant Luye Pharma, spends $700m on Australia’s third largest hospital operator to help ‘designing and managing Chinese hospitals’, it is clear that the Chinese healthcare industry is looking to Westernise. But the country is still a difficult market to enter.
Healthe Care, Australia’s third largest hospital operator, sold to Chinese provider Luye Medical Group for $700m (A$938m). Luye aims to import Healthe Care’s management expertise to China and is planning a $234m (A$300m) hospital expansion plan in Australia.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.